Favorable Clinical Data for Applaud Medical’s Novel Technology for Treating Urinary Stones Presented During the 2024 AUA Annual Meeting
06 Mayo 2024 - 7:00AM
Business Wire
Applaud Medical, an emerging leader in the treatment of urinary
stones, today announced positive results from a prospective,
multicenter study of the company’s BRIO Enhanced Lithotripsy System
(ELS) for the treatment of obstructive ureteral stones. The results
were presented as a podium presentation during the American
Urological Association's (AUA) 2024 Annual Meeting held in San
Antonio, Texas. The study combined Applaud Medical’s proprietary
acoustically enhanced microbubbles with a low-pressure ultrasound
system to treat ureteral stones. When assessed by CT-scan 30 days
following the procedure, 72% of the patients who underwent the
treatment had no urinary stone fragment greater than 3 millimeters
following a single treatment.
“Our study provided initial clinical data demonstrating the
safety and efficacy of acoustic cavitation lithotripsy for the
treatment ureteral stone disease,” stated Scott Wiener, MD,
Assistant Professor of Urology and Director of the Kidney Stone
Program at SUNY Upstate Medical University in Syracuse, New York.
“The single treatment stone free rate we observed in this study
exceeded that previously reported for both the spontaneous passage
of ureteral stones (adjusted for size and location), as well as
shockwave lithotripsy of ureteral stones. These data provide the
foundation for further clinical research using this exciting new
approach to urinary stone management.”
“The currently available options for treatment of urinary stones
often require patients to wait extended periods of time prior to
obtaining surgical treatment while enduring both the pain and
disruption to their lives,” said Paul Molloy, CEO of Applaud
Medical. “We are developing the BRIO System to change the standard
of care, combining our patented calcium-seeking microbubbles with
our proprietary low-pressure ultrasound console and ultrasound beam
sensing catheter to treat patients suffering with urinary stone
disease. Our solution aims to eliminate ureteral stones quickly,
affordably, and without general anesthesia or fluoroscopy, bringing
it to a physician’s office and other non-hospital settings.”
About Applaud Medical
Applaud Medical is a privately held company which aims to
improve treatment methods, patient experiences and medical costs
for all patients experiencing the effects of urinary stones. The
company’s initial technology is designed to offer patients and
healthcare professionals a fast, minimally invasive solution for
treating urinary stone disease in various clinical or outpatient
settings, eliminating the routine need for anesthesia or X-ray
imaging.
For more information, visit www.applaudmedical.com/
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240506482379/en/
Paul Molloy Chief Executive Officer Applaud Medical, Inc. Email:
paul.molloy@applaudmedical.com Tel: (415) 887-2037